Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 5.660

-1.0%

Jan 2 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: richardred	11/6/2004 12:39:11 AM
	Read Replies (1) of 7254

DSCP/ Medtronic Acquires Angiolink Corporation, Maker of Wound Closure Device for Vascular Procedures Thursday November 4, 9:00 am ET Angiolink's Innovative EVS(TM) Vascular Closure System Designed to Address the $500 Million Vascular Closure Market SANTA ROSA, Calif.--(BUSINESS WIRE)--Nov. 4, 2004-- Medtronic, Inc. (NYSE:MDT - News) announced today that it has acquired Angiolink Corporation, a privately held medical device company focused on developing innovative wound closure solutions for vascular procedures. Angiolink's EVS(TM) (Expanding Vascular Stapling) Vascular Closure System, which received FDA approval this week, is engineered to close the femoral artery access site after vascular procedures, such as diagnostic angiography, balloon angioplasty and stenting. Financial terms of the transaction were not disclosed.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next